Genetic Analysis AS - SER 2

NEW
XSAT:GEAN (Norway)   Unit (10 Ordinary shares,6 Wrts Ser 1 & 7 Wrts Ser 2)
kr 0.58 -0.064 (-10%) Aug 28
At Loss
P/B:
1.77
Market Cap:
kr 39.79M ($ 4.24M)
Enterprise V:
kr 28.49M ($ 3.04M)
Volume:
377.75K
Avg Vol (2M):
39.52K
Trade In:
Volume:
377.75K
At Loss
Avg Vol (2M):
39.52K

Genetic Analysis AS (XSAT:GEAN) Dividend

Genetic Analysis AS (XSAT:GEAN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -38.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XSAT:GEAN Dividend

Does Genetic Analysis AS (XSAT:GEAN) pay a dividend?

Genetic Analysis AS (XSAT:GEAN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Genetic Analysis AS pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Genetic Analysis AS has returned capital to shareholders via buybacks at a rate of -38.1% over the past 3 years.

What are dividend-paying alternatives to Genetic Analysis AS?

For dividend-paying alternatives in Genetic Analysis AS's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.